ANTI-PERTUSSIS IMMUNITY IN CHILDREN IN THE CITIES OF NORTHWESTERN FEDERAL DISTRICT WITH VARIOUS POPULATION


Cite item

Full Text

Abstract

Aim. Evaluate the state of immunity against pertussis in children living in St. Petersburg and regional centers of Northwestern Federal District (NFD). Materials and methods. The level of anti-pertussis antibodies by EIA and agglutinin reaction (AR) was studied in 419 children living in St. Petersburg and by AR in 239 children living in regional centers of NFD. Blood sera in AR were studied by using liquid pertussis diagnosticum (Biomed, Russia). Results. In St. Petersburg the frequency of detection of high level of antibodies was the highest in the 15 - 17 age group that indicates a high level of latent morbidity in grownups. The frequency of detection of high level of antibodies in the 3 - 4 and 9 - 10 age groups in regional centers was significantly lower, and the fraction of sera with undetected level of antibodies - significantly higher compared with St. Petersburg, that gives evidence on low circulation of causative agent, lack of «epidemizing» of children in small cities. Conclusion. The question of introduction of second revaccination against pertussis in children at the age of 6 is actual, because one vaccination is not enough for prolonged sustaining of population immunity intensity.

About the authors

N. N Kurova

Pasteur Research Institute of Epidemiology and Microbiology, St. Petersburg, Russia

G. Ya Tseneva

Pasteur Research Institute of Epidemiology and Microbiology, St. Petersburg, Russia

A. B Zhebrun

Pasteur Research Institute of Epidemiology and Microbiology, St. Petersburg, Russia

References

  1. Зайцев Е.М., Мазурова И.К., Краснопрошина Л.И. и др. Гуморальный противококлюшный иммунитет и распространенность коклюша в популяции. Журн. микробиол. 2009, 1: 56-58.
  2. Организация и проведение серологического мониторинга состояния коллективного иммунитета к инфекциям, управляемым средствами специфической профилактики (дифтерия, столбняк, коклюш, корь, краснуха, эпидемический паротит, полиомиелит, гепатит В). МУ 3.1.2943-11.
  3. Grimprel E., Begue P., Anjak I. et al. Long-term human serum antibody responses after immunization with whole-cell pertussis vaccine in France. Clin. Diagn. Lab. Immunol. 1996, 3 (1): 93-97.
  4. He Q., Viljanen M.K., Nikkari S. et al. Outcomes of Bordetella pertussis infection in different age groups of an immunized population. J. Infect. Dis. 1994, 170: 873-877.
  5. Konda T., Kamachi K., Iwaki M. et al. Distribution ofpertussis antibodies among different age groups in Japan. Vaccine. 2002, 20: 1711-1717.
  6. Lugauer S., Heininger U., Cherry J.D. et al. Long-term clinical effectiveness of an acellular pertussis component vaccine and a whole-cell pertussis component vaccine. Eur. J. Pediatr. 2002, 161 (3): 142-146.

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2013 Kurova N.N., Tseneva G.Y., Zhebrun A.B.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: ПИ № ФС77-75442 от 01.04.2019 г.


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies